UPDATE 2-Apricus mulls options; to sell U.S. rights to Vitaros By: Reuters: Company News April 16, 2018 at 08:25 AM EDT * Co has lost $65 mln in market cap since Feb rejection of Vitaros (Adds details on options, background, shares) Read More >> Related Stocks: Allergan Plc Apricus Biosc Inc Pfizer